Literature DB >> 15682282

Löfgren's syndrome: ureaplasmal association questioned.

D Taylor-Robinson.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15682282     DOI： 10.1007/s10096-005-1279-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  7 in total

1.  The role of Mycoplasma genitalium in non-gonococcal urethritis.

Authors:  D Taylor-Robinson; P J Horner
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  A case of urethritis due to Ureaplasma urealyticum associated with Löfgren's syndrome.

Authors:  M López-Gómez; P Gómez-Avivar; M A López-Ruz; J Jiménez-Alonso
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

3.  Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays.

Authors:  F Kong; Z Ma; G James; S Gordon; G L Gilbert
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

4.  Relationship of Ureaplasma urealyticum biovar 2 to nongonococcal urethritis.

Authors:  K Povlsen; E Bjørnelius; P Lidbrink; I Lind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-02       Impact factor: 3.267

5.  Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001.

Authors:  Janet A Robertson; Gerald W Stemke; John W Davis; Ryĵ Harasawa; David Thirkell; Fanrong Kong; Maurice C Shepard; Denys K Ford
Journal:  Int J Syst Evol Microbiol       Date:  2002-03       Impact factor: 2.747

6.  The male reservoir of Ureaplasma urealyticum.

Authors:  D Taylor-Robinson
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec

7.  Association of Ureaplasma urealyticum (biovar 2) with nongonococcal urethritis.

Authors:  Takashi Deguchi; Takashi Yoshida; Takamaro Miyazawa; Mitsuru Yasuda; Masayoshi Tamaki; Hiroaki Ishiko; Shin-Ichi Maeda
Journal:  Sex Transm Dis       Date:  2004-03       Impact factor: 2.830
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.